Bifidobacterium adolescentis (DSM 20083) and Lactobacillus casei (Lafti L26-DSL): Probiotics Able to Block the In Vitro Adherence of Rotavirus in MA104 Cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1867-1314
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bifidobacterium adolescentis (DSM 20083) and Lactobacillus casei (Lafti L26-DSL): Probiotics Able to Block the In Vitro Adherence of Rotavirus in MA104 Cells ; day:21 ; month:4 ; year:2017 ; pages:1-8
Probiotics and Antimicrobial Proteins ; (21.4.2017), 1-8
- Creator
-
Fernandez-Duarte, Karem Prunella
- Contributor
-
Olaya-Galán, Nury Nathalia
Salas-Cárdenas, Sandra Patricia
Lopez-Rozo, Jazmin
Gutierrez-Fernandez, Maria Fernanda
SpringerLink (Online service)
- DOI
-
10.1007/s12602-017-9277-7
- URN
-
urn:nbn:de:1111-201705058355
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fernandez-Duarte, Karem Prunella
- Olaya-Galán, Nury Nathalia
- Salas-Cárdenas, Sandra Patricia
- Lopez-Rozo, Jazmin
- Gutierrez-Fernandez, Maria Fernanda
- SpringerLink (Online service)
Other Objects (12)
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?
Einfluß von Bifidobacterium adolescentis auf die humorale Immunreaktion gegen Bacteroides thetaiotaomicron
Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
Cell factory for γ-aminobutyric acid (GABA) production using Bifidobacterium adolescentis
Antiviral activity of Bifidobacterium adolescentisSPM1005-A on human papillomavirus type 16
Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
Bifidobacterium adolescentis-derived hypaphorine alleviates acetaminophen hepatotoxicity by promoting hepatic Cry1 expression
Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase
Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?
Einfluß von Bifidobacterium adolescentis auf die humorale Immunreaktion gegen Bacteroides thetaiotaomicron
Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
Cell factory for γ-aminobutyric acid (GABA) production using Bifidobacterium adolescentis
Antiviral activity of Bifidobacterium adolescentisSPM1005-A on human papillomavirus type 16
Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
Bifidobacterium adolescentis-derived hypaphorine alleviates acetaminophen hepatotoxicity by promoting hepatic Cry1 expression
Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase
Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentisG1
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?
Einfluß von Bifidobacterium adolescentis auf die humorale Immunreaktion gegen Bacteroides thetaiotaomicron
Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
Cell factory for γ-aminobutyric acid (GABA) production using Bifidobacterium adolescentis
Antiviral activity of Bifidobacterium adolescentisSPM1005-A on human papillomavirus type 16
Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
Bifidobacterium adolescentis-derived hypaphorine alleviates acetaminophen hepatotoxicity by promoting hepatic Cry1 expression
Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase